Suppr超能文献

抗结核DNA疫苗接种导致的肺坏死。

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

作者信息

Taylor Jennifer L, Turner Oliver C, Basaraba Randall J, Belisle John T, Huygen Kris, Orme Ian M

机构信息

Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

出版信息

Infect Immun. 2003 Apr;71(4):2192-8. doi: 10.1128/IAI.71.4.2192-2198.2003.

Abstract

The use of DNA constructs encoding mycobacterial proteins is a promising new approach to vaccination against tuberculosis. A DNA vaccine encoding the hsp60 molecule of Mycobacterium leprae has previously been shown to protect against intravenous infection of mice with Mycobacterium tuberculosis in both the prophylactic and immunotherapeutic modes. It is shown here, however, that this vaccine was not effective in a more realistic aerosol infection model or in a model of latent tuberculosis in the lungs. Moreover, when given in an immunotherapeutic model the immunized mice developed classical Koch reactions characterized by multifocal discrete regions of cellular necrosis throughout the lung granulomas. Similar and equally severe reactions were seen in mice given a vaccine with DNA coding for the Ag85 antigen of M. tuberculosis. This previously unanticipated safety problem indicates that DNA vaccines should be used with caution in individuals who may have already been exposed to tuberculosis.

摘要

使用编码分枝杆菌蛋白的DNA构建体是一种很有前景的新型结核病疫苗接种方法。先前已证明,编码麻风分枝杆菌hsp60分子的DNA疫苗在预防和免疫治疗模式下均能保护小鼠免受结核分枝杆菌的静脉感染。然而,本文表明,这种疫苗在更现实的气溶胶感染模型或肺部潜伏性结核模型中无效。此外,在免疫治疗模型中给予该疫苗时,免疫小鼠会出现典型的科赫反应,其特征是整个肺肉芽肿中出现多灶性离散的细胞坏死区域。在给予编码结核分枝杆菌Ag85抗原的DNA疫苗的小鼠中也观察到了类似且同样严重的反应。这个先前未预料到的安全问题表明,对于可能已经接触过结核病的个体,应谨慎使用DNA疫苗。

相似文献

1
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
Infect Immun. 2003 Apr;71(4):2192-8. doi: 10.1128/IAI.71.4.2192-2198.2003.
3
The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
Vaccine. 2008 Nov 11;26(48):6092-8. doi: 10.1016/j.vaccine.2008.09.011. Epub 2008 Sep 20.
4
DNA vaccines against tuberculosis.
Novartis Found Symp. 1998;217:239-46; discussion 246-53. doi: 10.1002/0470846526.ch18.
7
Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models.
Gene Ther. 2012 May;19(5):570-5. doi: 10.1038/gt.2011.140. Epub 2011 Sep 29.

引用本文的文献

1
A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults.
Front Immunol. 2024 Nov 14;15:1427371. doi: 10.3389/fimmu.2024.1427371. eCollection 2024.
2
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.
Front Cell Infect Microbiol. 2023 Jun 21;13:1146571. doi: 10.3389/fcimb.2023.1146571. eCollection 2023.
3
The Pathogenesis of Tuberculosis-The Koch Phenomenon Reinstated.
Pathogens. 2020 Oct 4;9(10):813. doi: 10.3390/pathogens9100813.
6
Tuberculosis and lung damage: from epidemiology to pathophysiology.
Eur Respir Rev. 2018 Feb 28;27(147). doi: 10.1183/16000617.0077-2017. Print 2018 Mar 31.
7
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis.
Front Immunol. 2018 Jan 15;8:1973. doi: 10.3389/fimmu.2017.01973. eCollection 2017.
8
components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice.
NPJ Vaccines. 2016 Sep 15;1:16012. doi: 10.1038/npjvaccines.2016.12. eCollection 2016.
9
bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
PLoS One. 2017 Jun 28;12(6):e0179513. doi: 10.1371/journal.pone.0179513. eCollection 2017.
10
Permutations of time and place in tuberculosis.
Lancet Infect Dis. 2015 Nov;15(11):1357-60. doi: 10.1016/S1473-3099(15)00135-8. Epub 2015 Aug 28.

本文引用的文献

2
Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice.
Infect Immun. 2002 Apr;70(4):2100-7. doi: 10.1128/IAI.70.4.2100-2107.2002.
3
Immunology of tuberculosis.
Annu Rev Immunol. 2001;19:93-129. doi: 10.1146/annurev.immunol.19.1.93.
4
Tuberculosis vaccine development: recent progress.
Trends Microbiol. 2001 Mar;9(3):115-8. doi: 10.1016/s0966-842x(00)01949-1.
6
Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.
Infect Immun. 2000 Mar;68(3):1706-9. doi: 10.1128/IAI.68.3.1706-1709.2000.
7
Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice.
Infect Immun. 2000 Mar;68(3):1231-4. doi: 10.1128/IAI.68.3.1231-1234.2000.
8
Beyond BCG: the potential for a more effective TB vaccine.
Mol Med Today. 1999 Nov;5(11):487-92. doi: 10.1016/s1357-4310(99)01594-4.
10
Reactivation of latent tuberculosis: variations on the Cornell murine model.
Infect Immun. 1999 Sep;67(9):4531-8. doi: 10.1128/IAI.67.9.4531-4538.1999.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验